Google Übersetzer
Avalyn Pharma Inc.
About
29.84USD-0.78 -2.55%
Closed • Updated at 05:36 GMT+00:00Market Cap$1.25B
Volume205.0K
Avalyn Pharma Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 5 2026
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
May 1 2026
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 30 2026
Avalyn Announces Pricing of Upsized Initial Public Offering
Apr 27 2026
Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury
Apr 6 2026
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
Recent Videos
The story behind the news: Avalyn Pharma files for an IPO.
Apr 09, 2026
MIST PPF Clinical Trial Overview Studying inhaled Pirfenidone in the treatment of PPF
Mar 26, 2026
Season 2, Episode 24: The Growth Equation with Allison Trucillo
Dec 15, 2025
Avalyn Pharma is developing a novel inhaled formulation of pirfenidone for IPF.
Jul 22, 2025